| 2025 |
Kamath, S., Sokolenko, E., Collins, K., Chan, N. S. L., Mills, N., Clark, S. R., . . . Joyce, P. (2025). IUPHAR Themed Review: The Gut Microbiome in Schizophrenia.. Pharmacological Research, 211(107561), 107561-1-107561-13.
DOI Scopus13 WoS10 Europe PMC10 |
| 2025 |
Wright, L., Wignall, A., Subramaniam, S., Schultz, H. B., Joyce, P., & Prestidge, C. A. (2025). Enhanced oral absorption and biodistribution to submandibular salivary glands of D-limonene in Sprague Dawley rats via a liquid-lipid formulation approach. International Journal of Pharmaceutics, 670(125179), 125179.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Kamath, S., Bryant, R. V., Costello, S. P., Day, A. S., Forbes, B., Haifer, C., . . . Joyce, P. (2025). Translational strategies for oral delivery of faecal microbiota transplantation. Gut, online(12), 1-22.
DOI Scopus7 WoS7 Europe PMC5 |
| 2025 |
Kamath, S., Sokolenko, E., Clark, S. R., Cross, C. B., Scott, J., Wardill, H. R., . . . Joyce, P. (2025). Distinguishing the causative, correlative and bidirectional roles of the gut microbiota in mental health. nature mental health, 3(10), 1137-1151.
DOI |
| 2025 |
Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., . . . Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Pt 1), 15 pages.
DOI |
| 2025 |
Taheri, A., Almasri, R., Wignall, A., Feltrin, F., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2025). Enteric coating enhances the Biopharmaceutical performance of a silica-lipid formulation of Abiraterone Acetate. Pharmaceutics, 17(10, article no. 1289), 1-12.
DOI |
| 2025 |
Kamath, S., & Joyce, P. (2025). A critical need for 'gut neutrality': mitigating adverse drug-microbiome interactions. Expert Opinion on Drug Metabolism and Toxicology, 21(1), 1-4.
DOI |
| 2025 |
Kamath, S., Ariaee, A., Abdelhafez, A., Asif, Z., Chan, N. S. L., Collins, K., . . . Joyce, P. (2025). Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release. Advanced Drug Delivery Reviews, 227(115720), 1-23.
DOI |
| 2025 |
Abdelhafez, A., Khabir, Z., Prestidge, C. A., Garcia Bennett, A., & Joyce, P. (2025). Impact of formulation design on the oral bioavailability of omega-3 polyunsaturated fatty acids. Food Research International, 208(116171), 1-16.
DOI |
| 2025 |
Minaei, E., Joyce, P., Wade, S. J., Brownlee, C., Penney, C., Ranson, M., . . . Vine Perrow, K. L. (2025). Gut microbial diversity is preserved through localised chemo-immunotherapy delivery in a KPC mouse model of pancreatic cancer. Journal Of Controlled Release, 386(114143), 1-11.
DOI |
| 2024 |
Subramaniam, S., Joyce, P., & Prestidge, C. A. (2024). The biomolecule corona mediates pulmonary delivery of nanomedicine. European Journal of Pharmaceutics and Biopharmaceutics, 202(114420), 1-8.
DOI |
| 2024 |
Ahsan, A., Thomas, N., Barnes, T. J., Subramaniam, S., Loh, T. C., Joyce, P., & Prestidge, C. A. (2024). Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics, 16(3, article no. 396), 1-46.
DOI |
| 2024 |
Subramaniam, S., Joyce, P., Conn, C. E., & Prestidge, C. A. (2024). Cellular uptake and in vitro antibacterial activity of lipid-based nanoantibiotics are influenced by protein corona. Biomaterials Science, 12(13), 3411-3422.
DOI |
| 2024 |
Iscaro, J., Yu, H., Martinez, N., Subramaniam, S., Joyce, P., Wang, H., . . . Zhai, J. (2024). Lyotropic liquid crystalline phase nanostructure and cholesterol enhance lipid nanoparticle mediated mRNA transfection in macrophages. Advanced Functional Materials, 34(no. 46, article no. 2405286), 1-15.
DOI Scopus11 WoS13 |
| 2024 |
Ariaee, A., Salim, M., Boyd, B. J., Prestidge, C., & Joyce, P. (2024). Montmorillonite restricts free fatty acid liberation and alters self-assembled structures formed during in vitro lipid digestion. Journal of Colloid and Interface Science, 675, 660-669.
DOI |
| 2024 |
Kerstens, R., & Joyce, P. (2024). The gut microbiome as a catalyst and emerging therapeutic target for Parkinson's Disease: a comprehensive update. Biomedicines, 12(8, article no. 1738), 1-35.
DOI |
| 2024 |
Taheri, A., Almasri, R., Wignall, A., Schultz, H. B., Elz, A. S., Ariaee, A., . . . Prestidge, C. A. (2024). Enhancing the pharmacokinetics of abiraterone acetate through lipid-based formulations: addressing solubility and food effect challenges. Drug Delivery and Translational Research, online(11), 3770-3782.
DOI WoS2 Europe PMC1 |
| 2024 |
Meola, T. R., Kamath, S., Elz, A. S., Prestidge, C. A., Wignall, A., & Joyce, P. (2024). Contrasting the pharmacokinetic performance and gut microbiota effects of an amorphous solid dispersion and lipid nanoemulsion for a poorly water-soluble anti-psychotic. European Journal of Pharmaceutics and Biopharmaceutics, 203, 10 pages.
DOI Scopus2 WoS2 Europe PMC1 |
| 2024 |
Kamath, S., Hunter, A., Collins, K., Wignall, A., & Joyce, P. (2024). The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats. British Journal of Pharmacology, 181(22), 4531-4545.
DOI WoS10 Europe PMC10 |
| 2024 |
Meola, T. R., Elz, A., Wignall, A., Paxton, K., Hunter, A., Ariaee, A., . . . Joyce, P. (2024). Inulin-Lipid Core–Shell Microcapsules Target the Gut Microbiota and Mimic the Pharmaceutical Food Effect for Improved Oral Antipsychotic Delivery. Advanced Functional Materials, 34(40), 12 pages.
DOI Scopus14 WoS14 |
| 2024 |
Ariaee, A., Wardill, H. R., Wignall, A., Elz, A. S., Wright, L., Prestidge, C., & Joyce, P. (2024). Therapeutic Potential of Inulin-Coated MCT Microcapsules in Modulating the Gut Microbiome for Effective Treatment of Diet-Induced Obesity. Advanced Therapeutics, 8(3), 13 pages.
DOI |
| 2024 |
Joyce, P., Allen, C. J., Alonso, M. J., Ashford, M., Bradbury, M. S., Germain, M., . . . Santos, H. A. (2024). A translational framework to DELIVER nanomedicines to the clinic. Nature Nanotechnology, 19(11), 1597-1611.
DOI Scopus120 WoS110 Europe PMC74 |
| 2024 |
Brewer, K., Wignall, A., Bazeed, A., Gundsambuu, B., Kohlhagen, J., Yan, J., . . . Blencowe, A. (2024). Customizable and Open-Source 3D Printed Inserts for Controlled Release and Cell Culture Experiments. ACS Applied Polymer Materials, 6(19), 11813-11827.
DOI |
| 2024 |
Ariaee, A., Koentgen, S., Wardill, H. R., Hold, G. L., Prestidge, C. A., Armstrong, H. K., & Joyce, P. (2024). Prebiotic selection influencing inflammatory bowel disease treatment outcomes: A review of the preclinical and clinical evidence. eGastroenterology, 2(2), 1-14.
DOI Scopus11 WoS10 Europe PMC6 |
| 2024 |
Ariaee, A., Wardill, H. R., Wignall, A., Prestidge, C. A., & Joyce, P. (2024). Correction: Ariaee et al. The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods 2024, 13, 1039. Foods, 13(24), 4030.
DOI |
| 2024 |
Subramaniam, S., Joyce, P., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C. M., & Prestidge, C. A. (2024). Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS Infectious Diseases, 10(2), 337-349.
DOI Scopus6 WoS6 Europe PMC6 |
| 2024 |
Nguyen, T. M., Joyce, P., Ross, D. M., Bremmell, K., Jambhrunkar, M., Wong, S. S., & Prestidge, C. A. (2024). Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax. Pharmaceutics, 16(2), 209-1-209-16.
DOI Scopus7 WoS5 Europe PMC3 |
| 2024 |
Revesz, I. A., Joyce, P., Ebert, L. M., & Prestidge, C. A. (2024). Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy. Clinical and Translational Immunology, 13(2, article no. e1492), 1-16.
DOI Scopus9 WoS9 Europe PMC7 |
| 2024 |
Ariaee, A., Wardill, H. R., Wignall, A., Prestidge, C. A., & Joyce, P. (2024). The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats. Foods, 13(7), 1039.
DOI Scopus11 WoS10 Europe PMC9 |
| 2024 |
Stringer, A. M., Hargreaves, B. M., Mendes, R. A., Blijlevens, N. M. A., Bruno, J. S., Joyce, P., . . . Wardill, H. R. (2024). Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 32(8), 558-1-558-15.
DOI Scopus11 WoS12 Europe PMC7 |
| 2024 |
Cross, C., Davies, M., Bateman, E., Crame, E., Joyce, P., Wignall, A., . . . Bowen, J. (2024). Fibre-rich diet attenuates chemotherapy-related neuroinflammation in mice. Brain, Behavior, and Immunity, 115, 13-25.
DOI Scopus12 WoS12 Europe PMC7 |
| 2023 |
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., . . . Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International Journal of Pharmaceutics, 648(123614), 123614-1-123614-10.
DOI Scopus31 WoS27 Europe PMC19 |
| 2023 |
Møller, A., Schultz, H. B., Meola, T. R., Joyce, P., Müllertz, A., & Prestidge, C. A. (2023). The Influence of Blonanserin Supersaturation in Liquid and Silica Stabilised Self-Nanoemulsifying Drug Delivery Systems on In Vitro Solubilisation. Pharmaceutics, 15(1), 14 pages.
DOI Scopus1 |
| 2023 |
Maghrebi, S., Thomas, N., Prestidge, C. A., & Joyce, P. (2023). Inulin-lipid hybrid (ILH) microparticles promote pH-triggered release of rifampicin within infected macrophages. Drug Delivery and Translational Research, 13(6), 1716-1729.
DOI |
| 2023 |
Subramaniam, S., Joyce, P., & Prestidge, C. A. (2023). Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus. International Journal of Pharmaceutics, 639(639, article no. 122927), 1-9.
DOI |
| 2023 |
Subramaniam, S., Kamath, S., Ariaee, A., Prestidge, C., & Joyce, P. (2023). The impact of common pharmaceutical excipients on the gut microbiota. Expert Opinion on Drug Delivery, 20(10), 1297-1394.
DOI |
| 2023 |
Hassan, M. M., Romana, B., Mao, G., Kumar, N., Sonvico, F., Thordarson, P., . . . Prestidge, C. A. (2023). Liposome-Micelle-Hybrid (LMH) carriers for controlled co-delivery of 5-FU and paclitaxel as chemotherapeutics. Pharmaceutics, 15(7, article no. 1886), 1-17.
DOI |
| 2023 |
Taheri, A., Bremmell, K. E., Joyce, P., & Prestidge, C. A. (2023). Battle of the milky way: lymphatic targeted drug delivery for pathogen eradication. Journal of Controlled Release, 363, 507-524.
DOI |
| 2023 |
Awad, M., Kopecki, Z., Barnes, T. J., Wignall, A., Joyce, P., Thomas, N., & Prestidge, C. A. (2023). Lipid Liquid Crystal Nanoparticles: Promising Photosensitizer Carriers for the Treatment of Infected Cutaneous Wounds. Pharmaceutics, 15(2), 1-18.
DOI Scopus6 WoS5 Europe PMC3 |
| 2023 |
Wright, L., Wignall, A., Jõemetsa, S., Joyce, P., & Prestidge, C. A. (2023). A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems. Drug Delivery and Translational Research, 13(4), 1088-1101.
DOI Scopus11 WoS12 Europe PMC10 |
| 2023 |
Nguyen, T. M., Jambhrunkar, M., Wong, S. S., Ross, D. M., Joyce, P., Finnie, J. W., . . . Prestidge, C. A. (2023). Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes.. Molecular pharmaceutics, 20(8), 3937-3946.
DOI Scopus8 WoS7 Europe PMC6 |
| 2023 |
Kamath, S., Stringer, A. M., Prestidge, C. A., & Joyce, P. (2023). Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery. Expert Opinion on Drug Delivery, 20(10), 1315-1331.
DOI Scopus23 WoS22 Europe PMC19 |
| 2023 |
Subramaniam, S., Joyce, P., Donnellan, L., Young, C., Wignall, A., Hoffmann, P., & Prestidge, C. A. (2023). Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles. Journal of Colloid and Interface Science, 641, 36-47.
DOI Scopus32 WoS31 Europe PMC23 |
| 2022 |
Wright, L., Barnes, T. J., Joyce, P., & Prestidge, C. A. (2022). Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics, 14(12), 2659.
DOI Scopus11 WoS10 Europe PMC5 |
| 2022 |
Joyce, P., Wignall, A., Peressin, K., Wright, L., Williams, D. B., & Prestidge, C. A. (2022). Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. International Journal of Pharmaceutics, 612(121382), 121382.
DOI Scopus15 WoS16 Europe PMC9 |
| 2022 |
Awad, M., Barnes, T. J., Thomas, N., Joyce, P., & Prestidge, C. A. (2022). Gallium Protoporphyrin Liquid Crystalline Lipid Nanoparticles: A Third-Generation Photosensitizer against Pseudomonas aeruginosa Biofilms. Pharmaceutics, 14(10), 2124.
DOI Scopus13 |
| 2022 |
Awad, M., Barnes, T. J., Joyce, P., Thomas, N., & Prestidge, C. A. (2022). Liquid crystalline lipid nanoparticle promotes the photodynamic activity of gallium protoporphyrin against S. aureus biofilms. Journal of Photochemistry and Photobiology B: Biology, 232(112474), 112474.
DOI Scopus17 Europe PMC9 |
| 2022 |
Almasri, R., Schultz, H. B., Møller, A., Bremmell, K. E., Garcia Bennett, A., Joyce, P., & Prestidge, C. A. (2022). Role of silica intrawall microporosity on abiraterone acetate solubilization and in vivo oral absorption. Molecular Pharmaceutics, 19(4), 1091-1103.
DOI |
| 2022 |
Chen, J., Hanrahan, J. P., McGrath, J., Courtney, M. A., Prestidge, C. A., & Joyce, P. (2022). The anti-obesity effect of porous silica is dependent on pore nanostructure, particle size, and surface chemistry in an in vitro digestion model. Pharmaceutics, 14(9, article no. 1813), 1-16.
DOI |
| 2022 |
Wang, W., Joyce, P., Bremmell, K., Milne, R., & Prestidge, C. A. (2022). Liposomal 5-fluorouracil polymer complexes facilitate tumor-specific delivery: pharmaco-distribution kinetics using microdialysis. Pharmaceutics, 14(2, article no. 221), 1-16.
DOI Scopus10 WoS8 Europe PMC6 |
| 2021 |
Subramaniam, S., Joyce, P., Thomas, N., & Prestidge, C. A. (2021). Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Advanced Drug Delivery Reviews, 177(113948), 1-23.
DOI |
| 2021 |
Olsén, E., Jõemetsa, S., González, A., Joyce, P., Zhdanov, V. P., Midtvedt, D., & Höök, F. (2021). Diffusion of lipid nanovesicles bound to a lipid membrane is associated with the partial-slip boundary condition. Nano Letters, 21(19), 8503-8509.
DOI |
| 2021 |
Hedge, O. J., Höök, F., Joyce, P., & Bergström, C. A. S. (2021). Investigation of self-emulsifying drug-delivery system interaction with a biomimetic membrane under conditions relevant to the small intestine. Langmuir, 37(33), 10200-10213.
DOI |
| 2021 |
Wright, L., Joyce, P., Barnes, T. J., Lundmark, R., Bergström, C. A. S., Hubert, M., & Prestidge, C. A. (2021). A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics. Journal of Pharmaceutical Sciences, 110(1), 217-227.
DOI Scopus9 WoS11 Europe PMC7 |
| 2021 |
Wright, L., Joyce, P., Barnes, T. J., & Prestidge, C. A. (2021). Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation. ACS Biomaterials Science & Engineering, 9(6), 19 pages.
DOI Scopus23 WoS24 Europe PMC14 |
| 2021 |
Meola, T., Abuhelwa, A. Y., Joyce, P., Clifon, P., & Prestidge, C. (2021). A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants. Drug Delivery and Translational Research, 11(3), 1261-1272.
DOI Scopus34 WoS31 Europe PMC22 |
| 2021 |
Meola, T. R., Joyce, P., Wignall, A., Bremmell, K. E., & Prestidge, C. A. (2021). Harnessing the potential of nanostructured formulations to mimic the food effect of lurasidone. International Journal of Pharmaceutics, 608(121098), 10 pages.
DOI Scopus11 WoS11 Europe PMC7 |
| 2020 |
Joyce, P., Dening, T. J., Meola, T. R., Wignall, A., Ulmefors, H., Kovalainen, M., & Prestidge, C. A. (2020). Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats. ACS Applied Bio Materials, 3(11), 7779-7788.
DOI Scopus13 WoS13 Europe PMC10 |
| 2020 |
Meola, T. R., Paxton, K., Joyce, P., Schultz, H. B., & Prestidge, C. A. (2020). The effect of drug ionization on lipid-based formulations for the oral delivery of anti-psychotics. Admet and Dmpk, 8(4), 437-451.
DOI Scopus9 WoS9 Europe PMC5 |
| 2020 |
Joyce, P., Meola, T. R., Schultz, H. B., & Prestidge, C. A. (2020). Biomaterials that regulate fat digestion for the treatment of obesity. Trends in Food Science and Technology, 100, 235-245.
DOI Scopus23 WoS19 |
| 2020 |
Maghrebi, S., Joyce, P., Jambhrunkar, M., Thomas, N., & Prestidge, C. A. (2020). Poly(lactic-co-glycolic) acid-lipid hybrid microparticles enhance the intracellular uptake and antibacterial activity of rifampicin. ACS, 12(7), 8030-8039.
DOI |
| 2020 |
Schultz, H. B., Joyce, P., Thomas, N., & Prestidge, C. A. (2020). Supersaturated-silica lipid hybrids improve in vitro solubilization of abiraterone acetate. Pharmaceutical Research, 37(4, article number. 77), 1.
DOI |
| 2020 |
Joyce, P., Ulmefors, H., Garcia Bennett, A., & Prestidge, C. A. (2020). Microporosity, pore size, and diffusional path length modulate lipolysis kinetics of triglycerides adsorbed onto SBA-15 mesoporous silica particles. Langmuir, 36(13), 3367-3376.
DOI |
| 2020 |
Almasri, R., Joyce, P., Schultz, H. B., Thomas, N., Bremmell, K. E., & Prestidge, C. A. (2020). Porous nanostructure, lipid composition, and degree of drug supersaturation modulate in vitro fenofibrate solubilization in silica-lipid hybrids. Pharmaceutics, 12(7, article no. 687), 1-22.
DOI |
| 2020 |
Maghrebi, S., Jambhrunkar, M., Joyce, P., & Prestidge, C. A. (2020). Engineering PLGA-lipid hybrid microparticles for enhanced macrophage uptake. ACS Applied Bio Materials, 3(7), 4159-4167.
DOI |
| 2019 |
Dening, T. J., Joyce, P., & Prestidge, C. A. (2019). Improving correlations between drug solubilization and in vitro lipolysis by monitoring the phase partitioning of lipolytic species for lipid-based formulations. Journal of pharmaceutical sciences, 108(1), 295-304.
DOI |
| 2019 |
Joyce, P., Dening, T. J., Meola, T. R., Schultz, H. B., Holm, R., Thomas, N., & Prestidge, C. A. (2019). Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges. Advanced drug delivery reviews, 142, 102-117.
DOI Scopus106 WoS94 Europe PMC69 |
| 2019 |
Joyce, P., Dening, T. J., Meola, T. R., Gustafsson, H., Kovalainen, M., & Prestidge, C. A. (2019). Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: an in vitro evaluation for the treatment of obesity. European journal of pharmaceutical sciences, 135, 1-11.
DOI Scopus15 WoS14 Europe PMC8 |
| 2019 |
Maghrebi, S., Prestidge, C. A., & Joyce, P. (2019). An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert opinion on drug delivery, 16(5), 507-524.
DOI |
| 2019 |
Wang, L., Song, Y., Parikh, A., Joyce, P., Chung, R., Liu, L., . . . Garg, S. (2019). Doxorubicin-loaded delta inulin conjugates for controlled and targeted drug delivery: development, characterization, and in vitro evaluation. Pharmaceutics, 11(11), 581-1-581-17.
DOI Scopus30 WoS25 Europe PMC19 |
| 2019 |
Dening, T. J., Joyce, P., Kovalainen, M., Gustafsson, H., & Prestidge, C. A. (2019). Spray dried smectite clay particles as a novel treatment against obesity. Pharmaceutical research, 36(1, article no. 21), 1-14.
DOI |
| 2018 |
Joyce, P., & Prestidge, C. A. (2018). Synergistic effect of PLGA nanoparticles and submicron triglyceride droplets in enhancing the intestinal solubilisation of a lipophilic weak base. European journal of pharmaceutical sciences, 118, 40-48.
DOI |
| 2018 |
Joyce, P., Gustafsson, H., & Prestidge, C. A. (2018). Enhancing the lipase-mediated bioaccessibility of omega-3 fatty acids by microencapsulation of fish oil droplets within porous silica particles. Journal of functional foods, 47, 491-502.
DOI |
| 2018 |
Joyce, P., Gustafsson, H., & Prestidge, C. A. (2018). Engineering intelligent particle-lipid composites that control lipase-mediated digestion. Advances in colloid and interface science, 260, 1-23.
DOI |
| 2018 |
Dening, T. J., Joyce, P., Webber, J. L., Beattie, D. A., & Prestidge, C. A. (2018). Inorganic surface chemistry and nanostructure controls lipolytic product speciation and partitioning during the digestion of inorganic-lipid hybrid particles. Journal of Colloid and Interface Science, 532, 666-679.
DOI |
| 2017 |
Joyce, P., Yasmin, R., Bhatt, A., Boyd, B. J., Pham, A., & Prestidge, C. A. (2017). Comparison across three hybrid lipid-based drug delivery systems for improving the oral absorption of the poorly water-soluble weak base cinnarizine. Molecular pharmaceutics, 14(11), 4008-4018.
DOI |
| 2017 |
Joyce, P., Dening, T. J., Gustafsson, H., & Prestidge, C. A. (2017). Modulating the lipase-mediated bioactivity of particle-lipid conjugates through changes in nanostructure and surface chemistry. European journal of lipid science and technology, 119(12, article no. 1700213), 1-9.
DOI |
| 2017 |
Wang, L., Barclay, T., Song, Y., Joyce, P., Sakala, I. G., Petrovsky, N., & Garg, S. (2017). Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant. Vaccine, 35(34), 4382-4388.
DOI Scopus18 WoS18 Europe PMC14 |
| 2016 |
Joyce, P., Kempson, I., & Prestidge, C. A. (2016). Orientating lipase molecules through surface chemical control for enhanced activity: A QCM-D and ToF-SIMS investigation. Colloids and Surfaces B Biointerfaces, 142, 173-181.
DOI Scopus32 WoS30 Europe PMC16 |
| 2016 |
Joyce, P., Whitby, C. P., & Prestidge, C. A. (2016). Nanostructuring biomaterials with specific activities towards digestive enzymes for controlled gastrointestinal absorption of lipophilic bioactive molecules. Advances in colloid and interface science, 237, 52-75.
DOI |
| 2016 |
Joyce, P., Whitby, C. P., & Prestidge, C. A. (2016). Interfacial processes that modulate the kinetics of lipase-mediated catalysis using porous silica host particles. RSC advances, 6(49), 43802-43813.
DOI |
| 2016 |
Dening, T. J., Joyce, P., Rao, S., Thomas, N., & Prestidge, C. A. (2016). Nanostructured montmorillonite clay for controlling the lipase-mediated digestion of medium chain triglycerides. ACS applied materials and interfaces, 8(48), 32732-32742.
DOI Scopus40 Europe PMC18 |
| 2016 |
Joyce, P., Barnes, T. J., Boyd, B. J., & Prestidge, C. A. (2016). Porous nanostructure controls kinetics, disposition and self-assembly structure of lipid digestion products. RSC advances, 6(82), 78385-78395.
DOI |
| 2015 |
Joyce, P., Whitby, C. P., & Prestidge, C. A. (2015). Bioactive hybrid particles from poly(D,L -lactide-co-glycolide) nanoparticle stabilized lipid droplets. ACS applied materials and interfaces, 7(31), 17460-17470.
DOI |
| 2015 |
Joyce, P., Kempson, I., & Prestidge, C. A. (2015). QCM-D and ToF-SIMS Investigation to Deconvolute the Relationship between Lipid Adsorption and Orientation on Lipase Activity. Langmuir, 31(37), 10198-10207.
DOI Scopus25 WoS25 Europe PMC14 |
| 2014 |
Joyce, P., Tan, A., Whitby, C. P., & Prestidge, C. A. (2014). The role of porous nanostructure in controlling lipase-mediated digestion of lipid loaded into silica particles. Langmuir, 30(10), 2779-2788.
DOI |
Available For Media Comment.